Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,279,928 papers from all fields of science
Search
Sign In
Create Free Account
simendan
Known as:
((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile
, Mesoxalonitrile (+/-)-(P-(1,4,5,6-Tetrahydro-4-Methyl-6-Oxo-3-Pyridazinyl)Phenyl)Hydrazone
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Broader (6)
Anti-Arrhythmia Agents
Cardiotonic Agents
Hydrazones
Phosphodiesterase Inhibitors
Expand
Narrower (4)
Levosimendan
OR 1259
OR-1855
dextrosimendan
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Enantiomeric analysis of simendan on polysaccharide-based stationary phases by polar organic solvent chromatography.
Lingping Cheng
,
Jianfeng Cai
,
Qing Fu
,
Yanxiong Ke
Journal of Separation Science
2020
Corpus ID: 212407066
Herein, the enantiomeric separation of simendan by HPLC with ultraviolet detection method using polysaccharide-based chiral…
Expand
2019
2019
The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP.
J. Li
,
X.Y. Wang
,
+4 authors
J. Yang
European Review for Medical and Pharmacological…
2019
Corpus ID: 162170901
OBJECTIVE Simendan is a calcium sensitizer that enhances myocardial contractility but does not affect ventricular diastole…
Expand
2017
2017
The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
M. Nieminen
,
C. Fonseca
,
D. Brito
,
G. Wikström
European Heart Journal, Supplement
2017
Corpus ID: 13653212
Abstract Maintaining adequate quality of life (QoL) is an important therapeutic objective for patients with advanced heart…
Expand
Review
2014
Review
2014
Levosimendan in Critical Illness: A Literature Review
C. Pierrakos
,
D. Velissaris
,
F. Franchi
,
L. Muzzi
,
M. Karanikolas
,
S. Scolletta
Journal of Clinical Medicine Research
2014
Corpus ID: 12375858
Levosimendan, the active enantiomer of simendan, is a calcium sensitizer developed for treatment of decompensated heart failure…
Expand
2004
2004
Enatiomeric analysis of simendan by CE with beta-CD as chiral selector compared with CMPA-HPLC.
Fa-mei Li
,
Dandan Zhang
,
Xiumei Lu
,
Yuling Wang
,
Z. Xiong
Biomedical chromotography
2004
Corpus ID: 24791524
The chiral separation of simendan enantiomers using capillary electrophoresis was studied with beta-cyclodextrin (beta-CD) as…
Expand
Highly Cited
2001
Highly Cited
2001
Improved survival with simendan after experimental myocardial infarction in rats.
J. Levijoki
,
Piero Pollesello
,
P. Kaheinen
,
H. Haikala
European Journal of Pharmacology
2001
Corpus ID: 4554242
1996
1996
Enantiomeric bioanalysis of simendan and levosimendan by chiral high-performance liquid chromatography.
T. Wikberg
,
T. Korkolainen
,
M. Karlsson
Chirality
1996
Corpus ID: 23083443
rac-Simendan, (+/-)-(R,S)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl ] hydrazono]propanedinitrile, and the…
Expand
Highly Cited
1994
Highly Cited
1994
Maltooligosaccharides as chiral selectors for the separation of pharmaceuticals by capillary electrophoresis.
H. Soini
,
Morgan Stefansson
,
M. Riekkola
,
Milos V. Novotny
Analytical Chemistry
1994
Corpus ID: 36932047
Complexation between the linear maltodextrin oligosaccharides and certain enantiomeric compounds of pharmaceutical interest in…
Expand
1994
1994
Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteers
J. Lilleberg
,
S. Antila
,
M. Karlsson
,
M. Nieminen
,
Pertti J Pentkäinen
Clinical pharmacology and therapy
1994
Corpus ID: 28405306
To assess pharmacokinetics and correlation of pharmacokinetics and pharmacodynamics of simendan, a new calcium‐sensitizing…
Expand
1994
1994
Hemodynamic effects of the novel cardiotonic drug simendan: Echocardiographic assessment in healthy volunteers
J. Lilleberg
,
S. Sundberg
,
T. Leikola-Pelho
,
M. Nieminen
Cardiovascular Drugs and Therapy
1994
Corpus ID: 2288225
SummarySimendan is a novel cardiotonic drug with mixed properties, including calcium sensitization. Simendan was given…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE